Correlation Between Surface Oncology and Iovance Biotherapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Surface Oncology and Iovance Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Surface Oncology and Iovance Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Surface Oncology and Iovance Biotherapeutics, you can compare the effects of market volatilities on Surface Oncology and Iovance Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Surface Oncology with a short position of Iovance Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Surface Oncology and Iovance Biotherapeutics.

Diversification Opportunities for Surface Oncology and Iovance Biotherapeutics

-0.25
  Correlation Coefficient

Very good diversification

The 3 months correlation between Surface and Iovance is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Surface Oncology and Iovance Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iovance Biotherapeutics and Surface Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Surface Oncology are associated (or correlated) with Iovance Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iovance Biotherapeutics has no effect on the direction of Surface Oncology i.e., Surface Oncology and Iovance Biotherapeutics go up and down completely randomly.

Pair Corralation between Surface Oncology and Iovance Biotherapeutics

If you would invest  837.00  in Iovance Biotherapeutics on September 1, 2024 and sell it today you would earn a total of  95.00  from holding Iovance Biotherapeutics or generate 11.35% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy0.79%
ValuesDaily Returns

Surface Oncology  vs.  Iovance Biotherapeutics

 Performance 
       Timeline  
Surface Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Surface Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Surface Oncology is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.
Iovance Biotherapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Iovance Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Surface Oncology and Iovance Biotherapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Surface Oncology and Iovance Biotherapeutics

The main advantage of trading using opposite Surface Oncology and Iovance Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Surface Oncology position performs unexpectedly, Iovance Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iovance Biotherapeutics will offset losses from the drop in Iovance Biotherapeutics' long position.
The idea behind Surface Oncology and Iovance Biotherapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites